Inactive Instrument
CannaVEST Corp Stock OTC Bulletin Board
Stocks
US1376531018
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-03 | CV Sciences, Inc. - Shareholder/Analyst Call | |
| 05-15 | CV Sciences, Inc., Q1 2026 Earnings Call, May 14, 2026 |
| Market Cap | 4.18M 3.67M 3.41M 3.14M 5.88M 404M 5.99M 40.8M 15.91M 197M 15.68M 15.34M 684M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.89M 5.18M 4.82M 4.43M 8.31M 571M 8.45M 57.58M 22.46M 278M 22.13M 21.65M 966M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
92.21% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CannaVEST Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 31/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 15/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 31/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 21/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 21/10/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.61% | +1.03% | +47.86% | +157.17% | 1,037B | ||
| +1.22% | +3.32% | +52.73% | +50.96% | 615B | ||
| +1.07% | +0.61% | +34.31% | +78.75% | 448B | ||
| +5.14% | +5.40% | +33.75% | +27.79% | 326B | ||
| +1.85% | +3.57% | +37.09% | +40.59% | 293B | ||
| -0.11% | +0.48% | +18.87% | +17.70% | 264B | ||
| +0.25% | -4.62% | -27.66% | -41.76% | 216B | ||
| +0.66% | -0.92% | +19.06% | +56.38% | 198B | ||
| -0.08% | -4.64% | +14.45% | +67.36% | 162B | ||
| Average | +1.27% | +1.12% | +25.61% | +50.55% | 395.27B | |
| Weighted average by Cap. | +1.47% | +1.47% | +34.97% | +75.40% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.81M 12.83M 11.8M 22.13M 1.52B 22.53M 153M 59.85M 742M 58.96M 57.68M 2.57B | 13.79M 12.13M 11.27M 10.36M 19.43M 1.34B 19.78M 135M 52.55M 651M 51.77M 50.65M 2.26B |
| Net income | -2.39M -2.11M -1.96M -1.8M -3.37M -232M -3.43M -23.39M -9.12M -113M -8.99M -8.79M -392M | -958K -843K -783K -720K -1.35M -92.77M -1.37M -9.36M -3.65M -45.25M -3.6M -3.52M -157M |
| Net Debt | 325K 286K 266K 244K 458K 31.47M 466K 3.18M 1.24M 15.35M 1.22M 1.19M 53.26M | 1.72M 1.51M 1.4M 1.29M 2.42M 166M 2.46M 16.79M 6.55M 81.15M 6.45M 6.31M 282M |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions

















